✦ LIBER ✦

Pharmacokinetics of a microcrystalline theophylline preparation in patients with chronic obstructive airways disease

✍ Scribed by R. K. Elwood; J. G. Kelly; D. G. McDevitt

Publisher: Springer
Year: 1978
Tongue: English
Weight: 521 KB
Volume: 13
Category: Article
ISSN: 0031-6970
DOI: 10.1007/bf00606679

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of theophylline in hype

Pharmacokinetics of theophylline in hyperthyroid and hypothyroid patients with chronic obstructive pulmonary disease

✍ M. Pokrajac; D. Simić; V. M. Varagić 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 450 KB

Effect of cimetidine and ranitidine on p

Effect of cimetidine and ranitidine on plasma theophylline in patients with chronic obstructive airways disease treated with theophylline and corticosteroids

✍ W. Boehning 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 290 KB

The pharmacokinetics of theophylline and

The pharmacokinetics of theophylline and enprofylline in patients with liver cirrhosis and in patients with chronic renal disease

✍ J. Kraan; J. H. G. Jonkman; G. H. Koëter; C. H. Gips; P. E. Jong; Th. W. Mark; I 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 516 KB

Pharmacokinetics of an ultralong sustain

Pharmacokinetics of an ultralong sustained-release theophylline formulation when given twice daily in elderly patients with chronic obstructive pulmonary disease: Monitoring implications

✍ Juan A. Armijo; Blanca M. Sánchez; F. Galo Peralta; Mario González-Ruiz; Antonio 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 1 views

Frequency and time domain analysis of ai

Frequency and time domain analysis of airflow breath patterns in patients with chronic obstructive airway disease

✍ Shimon Abboud; Israel Bruderman; Dror Sadeh 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 407 KB

Airflow patterns from patients with chronic obstructive airway diseases (COAD) and normal subjects were analyzed using time and frequency domain analysis. Data were recorded during tidal breathing with a pause between the breaths, digitized at 320 samples per second (IO-bit resolution), and processe

Pharmacokinetics of isradipine in patien

Pharmacokinetics of isradipine in patients with chronic liver disease

✍ J. Cotting; J. Reichen; K. Kutz; R. Laplanche; E. Nüesch 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 523 KB

The pharmacokinetics of the dihydropyridine calcium antagonist isradipine has been examined in 8 healthy volunteers, 7 patients with non-cirrhotic chronic liver disease (CLD), and 8 patients with biopsy-proven cirrhosis (CIR). Isradipine was simultaneously given orally (12C 5 mg) and i.v. (13C 1 mg)